An observational study in Lumbar Disc Herniation, sponsored by Jaseng Medical Foundation. Completed at 1 site in South Korea. Open to participants aged 19 Years to 69 Years. Per ClinicalTrials.gov, last updated 2023-03-03.
Sponsored by Jaseng Medical Foundation · Observational
Background: The selection of primary outcomes that reflect the real symptoms and conditions of patients is instrumental in clinical studies on the effectiveness of specific treatment modalities. This study aimed to explore the appropriate outcomes that reflect the real-world needs and concerns of patients with lumbar disc herniation (LDH) and provide a basis for designing related clinical trials.
Methods and Findings: This cross-sectional nationwide web-based survey study was conducted in South Korea in November 2022. Patients who were diagnosed with LDH and had LDH-related radiating leg pain were enrolled. The questionnaire consisted of 5 parts: basic characteristics, disease onset, symptom and severity, priority symptoms for improvement, and important factors in treatment. Overall, 500 patients (100 patients from the each age group) were enrolled.
489 studies on the registry are indexed under Intervertebral Disc Displacement; 104 are open to participants now.
This study's enrollment of 500 is above the median of 100 across 123 observational studies indexed under Intervertebral Disc Displacement.
Browse Intervertebral Disc Displacement studies →Jaseng Medical Foundation is the lead sponsor of 68 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All 19-69 patients who were diagnosed with LDH and had LDH-related radiating leg in Korea
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: No intervention
This is a survey study, and there were no intervention
survey basic characteristics
Time frame: 1 day
disease onset survey
Time frame: 1 day
symptom and its severity survey
Time frame: 1 day
priority symptoms for improvement survey
Time frame: 1 day
important factors in treatment survey
Time frame: 1 day
Plan to share: No
No publications or documents are linked to this record.
Ran from Nov 2022 to primary completion in Nov 2022, 0 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intervertebral Disc Displacement →
Jaseng Medical Foundation